论文部分内容阅读
目的探讨不同方案治疗脑梗死的经济效果。方法选择医院2010年5月-2014年4月收治的脑梗死患者291例,随机分为Ⅰ、Ⅱ、Ⅲ、Ⅳ、Ⅴ组,分别58例,59例,59例,57例,58例。分别给予疏血通、血栓通、丹红、血塞通、丹参川芎嗪注射液治疗,观察5组治疗效果及成本。结果Ⅰ~Ⅴ组患者治疗后总有效率分别为87.93%、88.13%、86.44%、87.72%、87.93%,差异无统计学意义(P>0.05)。5组中Ⅳ组治疗费用最高,Ⅲ组最低,与Ⅰ、Ⅱ、Ⅳ、Ⅴ组比较,差异有统计学意义(P<0.05)。与Ⅰ、Ⅱ、Ⅳ、Ⅴ组比较,Ⅲ组C/E最低,△C/△E最小,差异有统计学意义(P<0.05)。假设药物费用下降10%,其他费用不变。与Ⅰ、Ⅱ、Ⅳ、Ⅴ组比较,Ⅲ组C/E最低,△C/△E最小差异均有统计学意义(P<0.05)。结论脑梗死患者给予丹红注射液治疗,效果明显,成本较低。
Objective To investigate the economic effects of different regimens in treating cerebral infarction. Methods 291 patients with cerebral infarction admitted from May 2010 to April 2014 in our hospital were randomly divided into Ⅰ, Ⅱ, Ⅲ, Ⅳ and Ⅴ groups, 58 cases, 59 cases, 59 cases, 57 cases and 58 cases respectively. The rats were given Shuxuetong, Xueshuantong, Danhong, Xuesaitong and Danshen Ligustrazine Injection respectively. The therapeutic effect and cost of the five groups were observed. Results The total effective rates of patients in group Ⅰ ~ Ⅴ were 87.93%, 88.13%, 86.44%, 87.72% and 87.93%, respectively, with no significant difference (P> 0.05). The cost of treatment group Ⅳ was the highest in group 5, the lowest in group Ⅲ, and the difference was statistically significant compared with group Ⅰ, Ⅱ, Ⅳ and Ⅴ (P <0.05). Compared with Ⅰ, Ⅱ, Ⅳ and Ⅴ group, the C / E of group Ⅲ was the lowest, △ C / △ E was the smallest, the difference was statistically significant (P <0.05). Assuming a 10% drop in drug costs, other costs remain unchanged. Compared with Ⅰ, Ⅱ, Ⅳ, Ⅴ group, the lowest C / E in group Ⅲ, the smallest difference in △ C / △ E were statistically significant (P <0.05). Conclusion Danhong injection in patients with cerebral infarction treatment, the effect is obvious, the cost is lower.